Literature DB >> 758812

Serum prolactin and clinical state during neuroleptic treatment and withdrawal.

T P Laughren, W A Brown, B W Williams.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 758812     DOI: 10.1176/ajp.136.1.108

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  5 in total

1.  Long-term neuroleptic treatment of chronic schizophrenic patients: clinical and biochemical effects of withdrawal.

Authors:  K J Zander; B Fischer; R Zimmer; M Ackenheil
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

2.  Mechanisms of action of antipsychotic drugs of different classes, refractoriness to therapeutic effects of classical neuroleptics, and individual variation in sensitivity to their actions: Part II.

Authors:  R Miller
Journal:  Curr Neuropharmacol       Date:  2009-12       Impact factor: 7.363

3.  Serum neuroleptic activity, prolactin, and tardive dyskinesia in schizophrenic outpatients.

Authors:  J G Csernansky; J Kaplan; C A Holman; L E Hollister
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

4.  Prolactinemia is uncoupled from central D2/D3 dopamine receptor occupancy in amisulpride treated patients.

Authors:  Rodrigo A Bressan; Kjell Erlandsson; Edgar P Spencer; Peter J Ell; Lyn S Pilowsky
Journal:  Psychopharmacology (Berl)       Date:  2004-09       Impact factor: 4.530

5.  Assessment of central dopaminergic function using plasma-free homovanillic acid after debrisoquin administration.

Authors:  M A Riddle; J F Leckman; D J Cohen; M Anderson; S I Ort; K A Caruso; B A Shaywitz
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.